AR420626, a selective agonist of GPR41/FFA3, suppresses growth of hepatocellular carcinoma cells by inducing apoptosis

MLA

Daisuke, Mikami, et al. “AR420626, a Selective Agonist of GPR41/FFA3, Suppresses Growth of Hepatocellular Carcinoma Cells by Inducing Apoptosis.” Therapeutic Advances in Medical Oncology, vol. 12, Oct. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........77cf989ff155db41dd4025e5f05d393e&authtype=sso&custid=ns315887.

APA

Daisuke, M., Mamiko, K., Junsuke, U., Takashi, Y., Kazuko, K., Kazuhisa, N., Yudai, N., Sho, N., Seiji, Y., Takanobu, T., & Masayuki, I. (2019). AR420626, a selective agonist of GPR41/FFA3, suppresses growth of hepatocellular carcinoma cells by inducing apoptosis. Therapeutic Advances in Medical Oncology, 12.

Chicago

Daisuke, Mikami, Kobayashi Mamiko, Uwada Junsuke, Yazawa Takashi, Kamiyama Kazuko, Nishimori Kazuhisa, Nishikawa Yudai, et al. 2019. “AR420626, a Selective Agonist of GPR41/FFA3, Suppresses Growth of Hepatocellular Carcinoma Cells by Inducing Apoptosis.” Therapeutic Advances in Medical Oncology 12 (October). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........77cf989ff155db41dd4025e5f05d393e&authtype=sso&custid=ns315887.